Literature DB >> 11999167

Function and regulation of class II transactivator in the immune system.

Cheong-Hee Chang1, Tania S Gourley, Tyler J Sisk.   

Abstract

The class II transactivator (CIITA) is a potent and critical transcriptional regulator. It activates genes necessary for antigen presentation function. It also regulates cytokine gene expression in CD4 T cells. We recently found that CIITA prevents cell death by inhibiting Fas ligand (FasL) gene expression. Thus, CIITA regulates multiple immune responses. The activation and the repression function of CIITA are mediated by its interaction with other transcription factors. To activate the target gene, CIITA interacts with DNA binding proteins and recruits the coactivator CBP/p300 to the promoter forming an enhanceosome necessary for transcription. In addition, CIITA interacts with self. Inter- and intramolecular interactions of CIITA are essential for transactivation function. Each domain of CIITA has a distinct role and all domains are required for CIITA activity. However, the regulatory mechanisms of CIITA interaction with self and other proteins are poorly understood and remain to be investigated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11999167     DOI: 10.1385/IR:25:2:131

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  60 in total

1.  CREB regulates MHC class II expression in a CIITA-dependent manner.

Authors:  C S Moreno; G W Beresford; P Louis-Plence; A C Morris; J M Boss
Journal:  Immunity       Date:  1999-02       Impact factor: 31.745

2.  Associations and interactions between bare lymphocyte syndrome factors.

Authors:  A M DeSandro; U M Nagarajan; J M Boss
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Fas ligand-induced apoptosis as a mechanism of immune privilege.

Authors:  T S Griffith; T Brunner; S M Fletcher; D R Green; T A Ferguson
Journal:  Science       Date:  1995-11-17       Impact factor: 47.728

4.  Structural diversity of leucine-rich repeat proteins.

Authors:  A V Kajava
Journal:  J Mol Biol       Date:  1998-04-03       Impact factor: 5.469

5.  Activation and transdominant suppression of MHC class II and HLA-DMB promoters by a series of C-terminal class II transactivator deletion mutants.

Authors:  K C Chin; G Li; J P Ting
Journal:  J Immunol       Date:  1997-09-15       Impact factor: 5.422

Review 6.  Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches.

Authors:  S L Constant; K Bottomly
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

7.  A signature motif in transcriptional co-activators mediates binding to nuclear receptors.

Authors:  D M Heery; E Kalkhoven; S Hoare; M G Parker
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

8.  A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production.

Authors:  T Gourley; S Roys; N W Lukacs; S L Kunkel; R A Flavell; C H Chang
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

9.  Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

Authors:  S T Ju; D J Panka; H Cui; R Ettinger; M el-Khatib; D H Sherr; B Z Stanger; A Marshak-Rothstein
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

10.  Class II transactivator regulates the expression of multiple genes involved in antigen presentation.

Authors:  C H Chang; R A Flavell
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  6 in total

1.  Repression of CIITA by the Epstein-Barr virus transcription factor Zta is independent of its dimerization and DNA binding.

Authors:  Nicolae Balan; Kay Osborn; Alison J Sinclair
Journal:  J Gen Virol       Date:  2015-12-11       Impact factor: 3.891

Review 2.  The evolving role of semaphorins and plexins in the immune system: Plexin-A1 regulation of dendritic cell function.

Authors:  Brian P O'Connor; Jenny P-Y Ting
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.

Authors:  Suhani Thakker; Pravinkumar Purushothaman; Namrata Gupta; Shanthan Challa; Qiliang Cai; Subhash C Verma
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

4.  Molecular characterization of chicken class II transactivator gene.

Authors:  Gholamreza Nikbakht Brujeni; Mohammad Khosravi
Journal:  Immunogenetics       Date:  2014-10-24       Impact factor: 2.846

5.  The effect of class II transactivator mutations on bleomycin-induced lung inflammation and fibrosis.

Authors:  Yong Xu; Larry Luchsinger; Edgar C Lucey; Barbara D Smith
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-12       Impact factor: 6.914

6.  Role of plasmacytoid dendritic cells for aberrant class II expression in exocrine glands from estrogen-deficient mice of healthy background.

Authors:  Rieko Arakaki; Ai Nagaoka; Naozumi Ishimaru; Akiko Yamada; Satoko Yoshida; Yoshio Hayashi
Journal:  Am J Pathol       Date:  2009-04-09       Impact factor: 4.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.